Do you or anyone you know have bipolar depression and struggling with suicidal thoughts and/or actions?
You may be eligible for this study if you meet the following criteria:
• Ages 18-65
• Diagnosed with Bipolar Depression
• Currently having suicidal thoughts
• Understand and sign an informed consent document
This study will assess the ability of a new combination of investigational medications to decrease your symptoms of depression, reduce your suicidal thoughts and maintain stability.
Study participation will be up to 7 visits for 10 weeks.
You will be compensated for your time.
For more information, please contact:
STU00217372 A Randomized, Double-Blind Controlled Comparison of NRX-101 to Standard of Care for Patients with Bipolar Depression and Subacute Suicidal Ideation and Behavior
PI: Jeffrey Rado, MD
The Northwestern University IRB has approved this research study
Discussion
By posting you agree to the Terms and Privacy Policy.